Results 161 to 170 of about 14,085 (216)

[Glycemic control of type 2 diabetes: primary care pre-pandemic versus COVID-19 pandemic]. [PDF]

Rev Med Inst Mex Seguro Soc
Soto-Estrada G, Mares-Gutiérrez Y, García-Minjares M, Martínez-González A, Martínez-Franco AI.   +4 more
europepmc   +1 more source

[How to monitor prediabetes and patients at risk for diabetes. Regarding the validity of diagnostic tests]. [PDF]

Aten Primaria
Maria Tablado MA.
europepmc   +1 more source

[Comments on the article "Main factors associated with hypoglycemia in patients with type 2 diabetes"]. [PDF]

Rev Med Inst Mex Seguro Soc
Calleja-Alarcón S, Sánchez-Hurtado LA, Rivas-Ruiz R, Romero-Gutiérrez L.   +3 more
europepmc   +1 more source

Risk of complications in vascular surgery: development of a clinical predictive model. [PDF]

J Vasc Bras
Peres J, Toregeani JF, Vendrametto AJ.
europepmc   +1 more source

[Costs of pharmacological treatment in hypertension and type 2 diabetes mellitus]. [PDF]

Rev Med Inst Mex Seguro Soc
Figueroa-García J, Granados-García VM, Martínez-Barro D, Figueroa-Hernández MF, Palomo-Piñón S, Rojano-Mejía D.   +5 more
europepmc   +1 more source

[Implementation of hypertension and diabetes care pathways in two regions of the Brazilian NortheastImplementación de las líneas de cuidado para la hipertensión y la diabetes en dos regiones del nordeste brasileño]. [PDF]

Rev Panam Salud Publica
de Abreu-Silva EO, Uchimura LYT, Chrispim PP.   +2 more
europepmc   +1 more source

Adherencia terapéutica en adolescentes con diabetes mellitus tipo 1

Revista de Ciencias Médicas de Pinar del Río
Alfredo Novales Amado, Rosabel Novales Amado, Aurora García Morey, José Rafael Hernández Gómez, Reinaldo González Iglesias   +4 more
doaj  

[Management of type 2 diabetes mellitus in frail patients from the Perspective of Real-World Clinical Practice]. [PDF]

Aten Primaria
Miñana-Castellanos M, Ramon Granés M, Fernández Camins B, Navas Méndez E, Barrot de la Puente J, Lapena Estella C.   +5 more
europepmc   +1 more source

The Impact of Type 2 Diabetes Mellitus on Hepatic Fibrosis in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Cross-Sectional Study. [PDF]

GE Port J Gastroenterol
Mesquita P, Macedo C, Matos A, Henriques C, Carvalho A, Simão A.   +5 more
europepmc   +1 more source

The role of probiotics in modulating the gut microbiota as a potential inhibitor of diabetic kidney disease progression. [PDF]

J Bras Nefrol
Costa VCS, Pinheiro MM, Cabreira GT, Bustelli IB, Santos JF, Ventura S, Santos LSC, Vattimo MFF, Silva EO.   +8 more
europepmc   +1 more source